scPharmaceuticals Inc
SCPH5.285USD
+0.115+2.22%
交易中 （美東）報價延遲15分鐘
265.75M總市值
虧損本益比TTM
關於 scPharmaceuticals Inc 公司
scPharmaceuticals Inc. 是一家制藥公司。該公司專注於開發和商業化產品，以優化輸注療法的輸送、提高患者護理水平並降低醫療成本。該公司通過內部和戰略合作伙伴關係開發產品和解決方案，旨在擴大和提高特定急性疾病的門診護理。其主要候選產品 FUROSCIX 包括通過隨身輸注器輸送的呋塞米配方。FUROSCIX 是一種呋塞米配方，包含在預填充的 Crystal Zenith 藥筒中，通過一次性、可拋棄和可穿戴的隨身輸送系統進行皮下自我給藥。該公司的管道項目包括 SCP-111（呋塞米注射液）80mg/mL，這是一種研究性 pH 中性水性呋塞米配方，正在開發用於醫院環境外的皮下給藥，包括患者在家中自我給藥。
公司簡介
公司代碼SCPH
公司名稱scPharmaceuticals Inc
上市日期Nov 17, 2017
CEOMr. John H. Tucker
員工數量162
證券類型Ordinary Share
年結日Nov 17
公司地址25 Burlington Mall Road, Suite 203
城市BURLINGTON
上市交易所NASDAQ Global Select Consolidated
國家United States of America
郵編01803
電話16175170730
網址https://www.scpharmaceuticals.com/
公司代碼SCPH
上市日期Nov 17, 2017
CEOMr. John H. Tucker
公司高階主管
名稱
名稱/職務
職務
持股
持股變動
Mr. John H. Tucker
Mr. John H. Tucker
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
122.34K
-55.88%
Mr. Leonard D. Schaeffer
Mr. Leonard D. Schaeffer
Independent Director
Independent Director
111.90K
--
Ms. Rachael Nokes
Ms. Rachael Nokes
Chief Financial Officer
Chief Financial Officer
30.39K
-71.18%
Ms. Minnie Baylor-Henry, J.D.
Ms. Minnie Baylor-Henry, J.D.
Independent Director
Independent Director
--
--
Ms. Mette Kirstine Agger
Ms. Mette Kirstine Agger
Independent Director
Independent Director
--
--
Ms. Sara M. Bonstein
Ms. Sara M. Bonstein
Independent Director
Independent Director
--
--
Ms. Katherine Miranda
Ms. Katherine Miranda
Senior Manager - Corporate Communication
Senior Manager - Corporate Communication
--
--
Mr. Jack A. Khattar
Mr. Jack A. Khattar
Independent Chairman of the Board
Independent Chairman of the Board
--
-100.00%
Dr. Klaus Veitinger, M.D., Ph.D.
Dr. Klaus Veitinger, M.D., Ph.D.
Independent Director
Independent Director
--
--
Dr. William T. Abraham, M.D.
Dr. William T. Abraham, M.D.
Independent Director
Independent Director
--
--
查看更多
名稱
名稱/職務
職務
持股
持股變動
Mr. John H. Tucker
Mr. John H. Tucker
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
122.34K
-55.88%
Mr. Leonard D. Schaeffer
Mr. Leonard D. Schaeffer
Independent Director
Independent Director
111.90K
--
Ms. Rachael Nokes
Ms. Rachael Nokes
Chief Financial Officer
Chief Financial Officer
30.39K
-71.18%
Ms. Minnie Baylor-Henry, J.D.
Ms. Minnie Baylor-Henry, J.D.
Independent Director
Independent Director
--
--
Ms. Mette Kirstine Agger
Ms. Mette Kirstine Agger
Independent Director
Independent Director
--
--
Ms. Sara M. Bonstein
Ms. Sara M. Bonstein
Independent Director
Independent Director
--
--
收入明細
暫無數據
暫無數據
業務
地區
暫無數據
股東統計
更新時間: 5月16日 週五
更新時間: 5月16日 週五
持股股東
股東類型
持股股東
持股股東
佔比
OrbiMed Advisors, LLC
11.48%
Rubric Capital Management LP
9.04%
Luther King Capital Management Corp.
6.95%
Lytton (Laurence W)
5.58%
AIGH Capital Management, LLC.
5.49%
Other
61.45%
持股股東
持股股東
佔比
OrbiMed Advisors, LLC
11.48%
Rubric Capital Management LP
9.04%
Luther King Capital Management Corp.
6.95%
Lytton (Laurence W)
5.58%
AIGH Capital Management, LLC.
5.49%
Other
61.45%
股東類型
持股股東
佔比
Investment Advisor
26.77%
Private Equity
17.92%
Hedge Fund
15.19%
Investment Advisor/Hedge Fund
11.23%
Individual Investor
6.08%
Research Firm
3.79%
Venture Capital
2.27%
Bank and Trust
0.15%
Pension Fund
0.03%
Other
16.57%
機構持股
更新時間: 7月1日 週二
更新時間: 7月1日 週二
報告期間
機構數
持股數
持股佔比
持股變動
2025Q2
207
44.05M
83.43%
-9.61M
2025Q1
220
46.17M
87.73%
-9.39M
2024Q4
216
48.09M
96.18%
-7.84M
2024Q3
205
45.54M
91.15%
-1.25M
2024Q2
187
32.09M
87.10%
-11.64M
2024Q1
180
29.20M
80.96%
-13.79M
2023Q4
174
29.67M
82.49%
-9.34M
2023Q3
165
32.24M
89.90%
-5.09M
2023Q2
160
30.81M
85.97%
-2.10M
2023Q1
135
26.76M
76.80%
-865.96K
查看更多
股東持股明細
名稱
持股數
佔比
持股變動
變動比例
公告日期
OrbiMed Advisors, LLC
6.06M
11.48%
--
--
Mar 31, 2025
Rubric Capital Management LP
4.78M
9.04%
--
--
Mar 31, 2025
Luther King Capital Management Corp.
3.12M
5.91%
+263.26K
+9.21%
Mar 31, 2025
Lytton (Laurence W)
2.94M
5.58%
+1.12M
+61.35%
Sep 30, 2024
AIGH Capital Management, LLC.
3.10M
5.86%
--
--
Mar 31, 2025
Lundbeckfond Invest
2.86M
5.42%
+2.86M
--
Sep 30, 2024
BlackRock Institutional Trust Company, N.A.
2.15M
4.08%
+43.64K
+2.07%
Mar 31, 2025
The Vanguard Group, Inc.
1.99M
3.77%
-115.70K
-5.49%
Mar 31, 2025
Morgan Stanley & Co. LLC
1.65M
3.12%
-29.52K
-1.76%
Mar 31, 2025
Rice Hall James & Associates, LLC
1.40M
2.65%
+408.42K
+41.27%
Mar 31, 2025
查看更多
持股ETF
更新時間: 8月2日 週六
更新時間: 8月2日 週六
機構名稱
佔比
Invesco NASDAQ Future Gen 200 ETF
0.47%
iShares Micro-Cap ETF
0.03%
ProShares Ultra Nasdaq Biotechnology
0.02%
Invesco Nasdaq Biotechnology ETF
0.02%
Global X Russell 2000 ETF
0.01%
ProShares Hedge Replication ETF
0.01%
Proshares Ultra Russell 2000
0.01%
iShares Russell 2000 Growth ETF
0.01%
ProShares UltraPro Russell2000
0.01%
iShares Russell 3000 ETF
0%
查看更多
Invesco NASDAQ Future Gen 200 ETF
佔比0.47%
iShares Micro-Cap ETF
佔比0.03%
ProShares Ultra Nasdaq Biotechnology
佔比0.02%
Invesco Nasdaq Biotechnology ETF
佔比0.02%
Global X Russell 2000 ETF
佔比0.01%
ProShares Hedge Replication ETF
佔比0.01%
Proshares Ultra Russell 2000
佔比0.01%
iShares Russell 2000 Growth ETF
佔比0.01%
ProShares UltraPro Russell2000
佔比0.01%
iShares Russell 3000 ETF
佔比0%
分紅派息
近5年累計派現
0.00
美元
公告日期
分紅計劃
股權登記日
現金發放日
除權除息日
暫無數據
拆合股
公告日期
類型
比率
暫無數據
公告日期
類型
比率
暫無數據
